Top Story

Hispanic veterans with HCV at higher risk for cirrhosis, HCC

September 1, 2014

Hispanic veterans with hepatitis C virus infection had a higher risk for developing cirrhosis or hepatocellular carcinoma compared with African-American and non-Hispanic white patients, according to new study results.

Researchers, including Hashem B. El-Serag, MD, MSHS, and Fasiha Kanwal, MD, MSHS, of Baylor College of Medicine and Michael E. DeBakey Veterans Affairs Medical Center, Houston, collected and analyzed data from 149,407 patients (mean age, 52.5 years) in the Veterans Administration HCV Clinical Case Registry database between 2000 and 2009. All patients had active hepatitis C virus (HCV) viremia; 56.3% were non-Hispanic whites, 36.1% were African-Americans, 6% were Hispanic, and 1.6% were of other races.

In the Journals

Acquired rifampicin resistance more likely in HIV-coinfected patients

September 1, 2014
Patients with HIV and tuberculosis were more likely to develop acquired rifampicin resistance when treated with a thrice-weekly tuberculosis treatment compared with…
In the Journals

Ionic liquids show promise against biofilm-protected bacteria

August 31, 2014
Ionic liquids may be an effective resource in combating bacterial skin infections protected by biofilm, according to recent study data published in the Proceedings of

Scientists develop hand-held DNA sequencer for infectious diseases

August 30, 2014
New Zealand researchers have developed a novel, hand-held DNA assay capable of detecting suspected viruses and bacteria, as well as the severity of infection, according…
More News Headlines »

HPV Disease Update 2013: What Every Pediatric Health Care Professional Needs to Know

This activity is supported by an educational grant from Merck & Co., Inc.

This CME-certified activity is based on the slides and lectures of faculty presenting at the Infectious Diseases in
More »

Gene surgery effectively removes HIV-1 from human cells

July 29, 2014
PHILADELPHIA — Temple University researchers have successfully eradicated latent HIV-1 virus from cultured human…
More »

HCV Consults: Volume 1, Number 1

This activity is supported by educational grants from AbbVie and Genentech.

Physicians seldom experience a paradigm shift in disease management as great as that transpiring in HCV therapy. With…
More »